Mednet Logo

Would you treat endometrioid adenocarcinoma arising from an endometriosis lesion in a patient with prior hyst/BSO like an ovarian or endometrial primary?

Example: in a patient with a non-resectable pelvic mass involving the vagina but without evidence of distant disease, would you favor pelvic RT (as one might do for locoregional non-resectable endometrial) or systemic chemotherapy (as one might do for ovarian)?
Community PollStarted

Do you treat endometrioid adenocarcinoma in a patient with prior hyst/BSO as an ovarian or endometrial primary?

101 physicians have voted

Join Mednetto vote and see how they answered.

3 Answers
Mednet Member
Mednet MemberInvited Expert
Gynecologic Oncology · Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
Answered on

For a patient with prior hyst/BSO and now an endometriosis-associated endometrioid adenocarcinoma, I would start by getting next-generation sequencing and MSI/MMR testing of the tissue specimen that was used to make the diagnosis. This would allow for additional information and the potential use of ...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Gynecologic Oncology · Center of Hope
Answered on

In general, endometrioid adenocarcinomas arising in endometriosis after hysterectomy/BSO are classified as peritoneal carcinomas and are treated like ovarian cancer. Tumor molecular studies may add critical information in directing primary therapy.

Background:

Numerous epidemiologic studies have demon...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Vanderbilt-Ingram Cancer Center
Answered on

I've seen a few cases where patients with a history of prior TAH for non-oncologic reasons 2+ years earlier developed endometrioid adenocarcinoma of the vaginal cuff, +/- nodal regional disease.

We treat definitively similar to how we would approach vaginal recurrence of endometrial cancer assuming...

Join for free or sign in to see the full answer